Why the study?
The safety and effectiveness of zero-fluoro catheter ablation of tachyarrhythmias in patients with an antiarrhythmic device needed assessment.
Does zero fluoroscopy catheter ablation reduce radiation exposure and maintain safety compared to fluoroscopy-guided ablation in patients with antiarrhythmic devices?
Does zero fluoroscopy catheter ablation reduce radiation exposure and maintain safety compared to fluoroscopy-guided ablation in patients with antiarrhythmic devices?
Zero fluoroscopy catheter ablation is feasible, safe, and effective in patients with implanted antiarrhythmic devices, eliminating radiation exposure without increasing the risk of lead dislodgement.
Answers are grounded in this paper and cite their sources.
Supports zero-fluoroscopy ablation to eliminate radiation in device patients; leaves open randomized confirmation of lead safety.
Aim. To assess safety and effectiveness of zero fluoro catheter ablation (CA) of tachyarrhythmias in patients with antiarrhythmic device. Methods. One hundred ninety-seven patients with implanted antiarrhythmic device and indication for catheter ablation of tachyarrhythmias were included in retrospective study. In control group of patients n=63 (mean age 65.5±11.9 years) all procedures were performed under fluoroscopic guidance. In a study group, n=134 (mean age 66.1±15.6 years) all procedures were performed without the use of fluoroscopy. To reconstruct 3D anatomy we used navigation systems: magnet and impedance. In some cases we used intracardiac ultrasound. In the first group there were 65% of patients with pacemakers, 4.8% patients with implantable cardioverters-defibrillators and 30.2% of patients had cardiac resynchronization systems. In second 70.1%, 12.7% and 17.2% respectively. In control group CA was performed within 24 hours after device implantation in 13 patients (20.6%), in study group - 23 (17.2%). In the rest cohort of patients mean period between device implantation and CA was 29.26±28 months - in control group, 38.8±39 months. Antiarrhythmic device programming was performed before and right after CA. Results. Interventional catheter procedure was performed in 98.4% of patients in control group and in 98.5% of patients in study group. Radiation exposure in control group was 0.24 mZv, in study group 0 mZv. There were no conversions from zero fluoroscopy procedure to X -ray controlled due to different reasons. In control (fluoroscopy controlled) group 8 hours after CA ventricle lead dislodgement was diagnosed. Antiarrhythmic device in this patient was implanted 6 days before CA. There were no lead dislodgements or cardiac pacing disorders in study group. Conclusion. Zero fluoroscopy CA of tachyarrhythmias in patients with antiarrhythmc device is as safe and effective as standard fluoroscopy controlled procedure.
No takes yet. Share an insight, caveat, or question.
Кропоткин et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: